These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31339052)

  • 1. Controversies in the management of neuromyelitis optica spectrum disorder.
    Bruscolini A; La Cava M; Mallone F; Marcelli M; Ralli M; Sagnelli P; Greco A; Lambiase A
    Expert Rev Neurother; 2019 Nov; 19(11):1127-1133. PubMed ID: 31339052
    [No Abstract]   [Full Text] [Related]  

  • 2. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
    Wu Y; Zhong L; Geng J
    Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of neuromyelitis optica spectrum disorders - An update.
    Bruscolini A; Sacchetti M; La Cava M; Gharbiya M; Ralli M; Lambiase A; De Virgilio A; Greco A
    Autoimmun Rev; 2018 Mar; 17(3):195-200. PubMed ID: 29339316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
    Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
    Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuromyelitis optica].
    Ferrán C; Pedemonte V; Turcatti E; González G
    Medicina (B Aires); 2019; 79 Suppl 3():60-65. PubMed ID: 31603846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes.
    Alves Do Rego C; Collongues N
    Rev Neurol (Paris); 2018 Jun; 174(6):458-470. PubMed ID: 29685427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
    Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
    Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What You Need to Know About AQP4, MOG, and NMOSD.
    Prasad S; Chen J
    Semin Neurol; 2019 Dec; 39(6):718-731. PubMed ID: 31847043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saudi consensus recommendations on the management of Neuromyelitis Optica Spectrum Disorders (NMOSD).
    Shosha E; Aljarallah SA; Al Fugham N; Al-Jedai AH; Al Luqmani MM; Al Malik YM; Al Mudaiheem HY; Al Otaibi HS; Al Thekair FY; Al Thubaiti IA; Al Yafeai RH; Ben Slimane NS; Bunyan RF; Cupler EJ; Mubarki SM; Saeedi JA; Al Jumah MA
    Mult Scler Relat Disord; 2022 Oct; 66():104062. PubMed ID: 35908449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging therapeutic targets for neuromyelitis optica spectrum disorder.
    Tradtrantip L; Asavapanumas N; Verkman AS
    Expert Opin Ther Targets; 2020 Mar; 24(3):219-229. PubMed ID: 32070155
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Simaniv TO; Vasiliev AV; Askarova LS; Zakharova MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10. Vyp. 2):35-48. PubMed ID: 31934987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Optic Neuritis: A Neuromyelitis Optica Spectrum Disorder.
    Alam M; Haq MAU; Iqbal A; Ullah K; Nabi D
    J Coll Physicians Surg Pak; 2019 Apr; 29(4):379-380. PubMed ID: 30925966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis Optica Spectrum Disorders.
    Costello F
    Continuum (Minneap Minn); 2022 Aug; 28(4):1131-1170. PubMed ID: 35938660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.
    Montcuquet A; Collongues N; Papeix C; Zephir H; Audoin B; Laplaud D; Bourre B; Brochet B; Camdessanche JP; Labauge P; Moreau T; Brassat D; Stankoff B; de Seze J; Vukusic S; Marignier R;
    Mult Scler; 2017 Sep; 23(10):1377-1384. PubMed ID: 27885065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyelitis optica spectrum disorders: still evolving and broadening.
    Fujihara K
    Curr Opin Neurol; 2019 Jun; 32(3):385-394. PubMed ID: 30893099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
    Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromyelitis Spectrum Disorders.
    Weinshenker BG; Wingerchuk DM
    Mayo Clin Proc; 2017 Apr; 92(4):663-679. PubMed ID: 28385199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.
    Ungureanu A; de Seze J; Ahle G; Sellal F
    Rev Neurol (Paris); 2018 Dec; 174(10):675-679. PubMed ID: 30293882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.